Genomics Companies Take the Spotlight at InformedInvestors.com's 5th Beltway Biotechnology Stocks Forum Saturday June 3 in Falls Church
FALLS CHURCH, Va., May 19 /PRNewswire/ -- Individual investors are invited to learn first-hand why genomics companies hold promise both on Wall Street and in science circles at the Fifth Informed Investors Beltway Biotechnology Stocks Forum Saturday June 3 at the Fairview Park Marriott in Falls Church, VA.
Executives of several closely watched genomics companies will explain their businesses and financial prospects to investors. Also, keynote speaker Dr. Akhtar Samad, Director of Healthcare Research of Oscar Gruss & Co. of New York, will guide attendees through the genomics space, from both a scientific and financial perspective.
Companies presenting in the morning session are: Gene Logic (Nasdaq: GLGC); Genzyme Molecular (Nasdaq: GZMO); Isis Pharmaceuticals (Nasdaq: ISIP); Lynx Therapeutics (Nasdaq: LYNX), Sequenom (Nasdaq: SQNM), Targeted Genetics (Nasdaq: TGEN), Trega Biosciences (Nasdaq: TRGA), and Vysis (Nasdaq: VYSI). Senior management of the companies will give insights into strategic plans and prospects. Presentations are about 35 minutes, including time for questions from the audience.
During the afternoon session, executives from Human Genome Sciences (Nasdaq: HGSI), Genome Therapeutics (Nasdaq: GENE), Cell Genesys (Nasdaq: CEGE) and Vical (Nasdaq: VICL) will present.
The forum will run from 8:30 a.m.-3 p.m. Attendance costs $25 prepaid, $40 at the door, which includes a continental breakfast. To register, go to informedinvestors.com or call 800-992-4683 for more information.
The Falls Church event is one of three life sciences-oriented conferences organized by InformedInvestors.com in the next month. On Saturday May 20 in San Diego, InformedInvestors.com is producing the investor forum portion of BioSpace.com's "Biotech Beach 2000 Life Sciences Expo," a major event that features activities targeting all facets of the life sciences industry. Go to biospace.com for full information.
On Monday June 5, Informed Investors will host its Third Boston BioPharma Stocks Forum. Analyst Bill Tanner of SG Cowen will keynote. Companies presenting include: Biopure; Boston Life Sciences; Corvas; EPIX Medical; Genzyme Tissue Repair; ICN Pharmaceuticals; Isis Pharmaceuticals; OXiGENE; Photogen Technologies; Repligen; Ribozyme Pharmaceuticals; SafeScience; Sepracor; Transkaryotic Therapies and Trega Biosciences. Go to www.informedinvestors.com for more information.
InformedInvestors.com is the leading producer of online and offline industry-specific investment conferences for individual investors and offers a growing stable of resources for in-depth sector-analysis, including the popular "BioTalk" radio show, airing Wednesdays.
SOURCE InformedInvestors.com
CO: InformedInvestors.com; Gene Logic; Genzyme Molecular; Isis Pharmaceuticals; Lynx Therapeutics; Sequenom; Targeted Genetics; Trega Biosciences; Vysis; Human Genome Sciences; Genome Therapeutics; Cell Genesys; Vical
ST: Virginia
IN: FIN BIO
SU:
05/19/2000 07:30 EDT prnewswire.com |
